Diagnostic and therapeutic applications of iontophoresis

References

• Alvarez-Figueroa MJ, Delgado-Charro MB, Blanco-Mendez. (2001). Passive and iontophoretic penetration of methotrexate. Int J Pharm, 212, 101–107.
   PubMed Web of Science ®Google Scholar
• Ashburn M, Stepehen RL, Ackerman E, Petelenz TJ, Hare B, Pace NL, Hofman AA. (1992). Iontophoretic delivery of morphine for postoperative analgesia. J Pain Sympt Manage, 7, 27–33.
   PubMed Web of Science ®Google Scholar
• Banga A. (1998). Clinical applications of iontophoresis devices for topical dermatological delivery. In: Electrically Enhanced Transdermal Drug Delivery (pp. 57–74 ). London, UK: Taylor & Francis.
   Google Scholar
• Banga AK, Katakam M, Mitra R. (1995). Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int J Pharm, 116, 211–216.
   Web of Science ®Google Scholar
• Bose S, Ravis WR, Lin YL, Zhang L, Hofmann GA, Banga AK. (2001). Electrically-assisted transdermal delivery of buprenorphine. J Control Release, 73, 197–203.
   PubMed Web of Science ®Google Scholar
• Brand RM, Guy RH. (1995). Iontophoresis of nicotine in vitro: pulsatile drug delivery across the skin? J Control Release, 33, 285–292.
   Web of Science ®Google Scholar
• Burnette RR. (1989). Iontophoresis. In: Hadgraft J, Guy RH, eds. Transdermal Delivery Systems: Developmental Issues and Research Initiatives (pp. 247–291). New York: Marcel Dekker.
   Google Scholar
• Chang BK, Guthrie TH, Hayakawa K, Gangarosa LP. (1993). A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin. Arch Dermatol, 129, 425–427.
   PubMed Web of Science ®Google Scholar
• Cormier M, Chao ST, Gupta SK, Haak R. (1999). Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin-induced reactions in human subjects. J Pharm Sci, 88, 1030–1035.
   PubMed Web of Science ®Google Scholar
• Craane-van Hinsberg WH, Bax L, Flinterman NH, Verhoef J, Junginger HE, Bodde HE. (1994). Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance. Pharm Res, 11, 1296–1300.
   PubMed Web of Science ®Google Scholar
• Curdy C, Kalia YN, Guy RH. (2001). Noninvasive assessment of the effects of iontophoresis on human skin in vivo. J Pharm Pharmacol, 53, 769–777.
   PubMed Web of Science ®Google Scholar
• Curdy C, Kalia YN, Naik A, Guy RH. (2001). Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Control Release, 76, 73–79.
   PubMed Web of Science ®Google Scholar
• Degim IT, Ilbasmis S, Dundaroz R, Oguz Y. (2003). Reverse iontophoresis: a non-invasive technique for measuring blood urea level. Pediatr Nephrol, 18, 1032–1037.
   PubMed Web of Science ®Google Scholar
• Delgado-Charro MB. (2009). Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling. J Drug Deliv Sci Tech, 19, 75–88.
   Web of Science ®Google Scholar
• Delgado-Charro MB, Guy RH. (1995). Iontophoretic delivery of nafarelin across the skin. Int J Pharm, 117, 165–172.
   Web of Science ®Google Scholar
• Delgado-Charro MB, Guy RH. (2001). Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. S T P Pharm Sci, 11, 403–14.
   Web of Science ®Google Scholar
• Delgado-Charro MB, Guy RH. (2003). Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring. Pharm Res, 20, 1508–1513.
   PubMed Web of Science ®Google Scholar
• DiabetesNet.com. (2008). Animas GlucoWatch Update. Last accessed, April 8, 2009, at http://www.diabetesnet.com/ diabetes_technology/glucowatch.php.
   Google Scholar
• Eastman RC, Chase HP, Buckingham B, Hathout EH, Fuller-Byk L, Leptien A, Van Wyhe MM, Davis TL, Fermi SJ, Pechler H, Sahyun G, Lopatin M, Wang BY, Wei C, Bartkowiak M, Ginsberg BH, Tamada JA, Pitzer KR. (2002). Use of the GlucoWatch Biographer in children and adolescents with diabetes. Pediatr Diabetes, 3, 127–134.
   PubMedGoogle Scholar
• Eljarrat-Binstock E, Domb AJ. (2006). Iontophoresis: a non-invasive ocular drug delivery. J Control Release, 10, 479–489.
   Google Scholar
• Ellens H, Lai Z, Marcello J, Davis CB, Cheng HY, Oh, CK, Okabe K. (1997). Transdermal iontophoretic delivery of (3H)GHRP in rats. Int J Pharm, 159, 1–11.
   Google Scholar
• EMEA. (2005). Last accessed, March 28, 2009, at http://www.emea.europa.eu/humandocs/Humans/EPAR/ionsys/ionsys.htm.
   Google Scholar
• EMEA. (2007). Last accessed, March 28, 2009, at http://www.emea.europa.eu/humandocs/PDFs/EPAR/ionsys/061206en6.pdf.
   Google Scholar
• Fang JY, Sung KC, Lin HH, Fang CL. (1999). Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm, 178, 83–92.
   PubMed Web of Science ®Google Scholar
• Galinkin JL, Rose JB, Harris K, Watcha MF. (2002). Lidocaine iontophoresis versus eutectic mixture of local anesthetics (EMLA) for IV placement in children. Anesth Analg, 94, 1484–1489.
   PubMed Web of Science ®Google Scholar
• Gangarosa LP, Ozawa A, Ohkido M, Shimomura Y. (1995). Iontophoresis for enhancing penetration of dermatologic and antiviral drugs. J Dermatol, 22, 865–875.
   PubMedGoogle Scholar
• Gibson LE, Cooke RE. (1959). A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics, 23, 545–549.
   PubMed Web of Science ®Google Scholar
• Glikfeld P, Hinz RS, Guy RH. (1989). Noninvasive sampling of biological fluids by iontophoresis. Pharm Res, 6, 988–990.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Southam M, Sathyan G, Klasuner M. (1998). Effect of current density on pharmacokinetics following continuous or intermittent input from fentanyl electrotransport system. J Pharm Sci, 87, 976–981.
   PubMed Web of Science ®Google Scholar
• Hao J, Li SK. (2008a). Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. J Pharm Sci, 97, 893–905.
   PubMed Web of Science ®Google Scholar
• Hao J, Li SK. (2008b). Mechanistic study of electorosmotic transport across hydrated nail plates: effects of pH and ionic strength. J Pharm Sci, 97, 5186–5197.
   PubMed Web of Science ®Google Scholar
• Heit MC, Monteiro-Riviere NA, Jayes FL, Riviere JE. (1994). Transdermal iontophoretic delivery of luteinizing hormone releasing hormone: effect of repeated administration. Pharm Res, 11, 1000–1003.
   PubMed Web of Science ®Google Scholar
• Herndon CM. (2007). Iontophoretic drug delivery system: focus on fentanyl 2007. Pharmacotherapy, 27, 745–754.
   PubMed Web of Science ®Google Scholar
• Hirvonen J, Guy RH. (1997). Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm Res, 14, 1258–1263.
   PubMed Web of Science ®Google Scholar
• Holzle E, Alberti N. (1987). Long-term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosis—the usefulness of home therapy. Dermatologica, 175, 126–135.
   PubMedGoogle Scholar
• Irsfeld S, Klement W, Lipfert P. (1993). Dermal anesthesia: comparison of EMLA cream with iontophoretic local anaesthesia. Br J Anaesth, 71, 375–378.
   PubMed Web of Science ®Google Scholar
• Jadoul A, Preat V. (1997). Electrically-enhanced transdermal delivery of domperidone. Int J Pharm, 154, 229–234.
   Google Scholar
• Jadoul A, Bouwstra J, Preat V. (1999). Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Del Rev, 35, 89–105.
   PubMed Web of Science ®Google Scholar
• Jadoul A, Mesens, Caers W, de Beukelaar F, Crabbe R, Preat V. (1996). Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm Res, 23, 175–182.
   Google Scholar
• Jain A, Ghosh B, Rajgor N, Desai BG. (2008). Passive and iontophoretic permeation of glipizide. Eur J Pharm Biopharm, 69, 958–963.
   PubMed Web of Science ®Google Scholar
• Jain KK. (2008). Transdermal Drug Delivery. Technologies, Companies & Markets. A Jain Pharma Biotech Report.
   Google Scholar
• James MP, Graham RM, English J. (1986). Percutaneous iontophoresis of prednisolone—a pharmacokinetic study. Clin Exp Dermatol, 11, 54–61.
   PubMed Web of Science ®Google Scholar
• Kalia YN, Naik A, Garrison J, Guy RH. (2004). Iontophoretic drug delivery. Adv Drug Del Rev, 56, 619–658.
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Singh J, Ramarao P. (2000). Transdermal iontophoretic delivery of timolol maleate in albino rabbits. Int J Pharm, 197, 69–76.
   PubMed Web of Science ®Google Scholar
• Kankkunen T, Sulkava R, Vuorio M Kontturi K, Hirvonen J. (2002). Transdermal iontophoresis of tacrine in vivo. Pharm Res, 19, 704–707.
   PubMed Web of Science ®Google Scholar
• Kasha PC, Banga AK. (2008). A review of patent literature for iontophoretic delivery and devices. Recent Patents Drug Deliv Formul, 2, 41–50.
   PubMedGoogle Scholar
• Langkjaer L, Brange J, Grodsky GM, Guy RH. (1998). Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment. J Control Release, 51, 47–56.
   PubMed Web of Science ®Google Scholar
• Lau DT, Sharkey JW, Petryk L, Mancuso FA, Yu Z, Tse FL. (1994). Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit. Pharm Res, 11, 1742–1746.
   PubMed Web of Science ®Google Scholar
• Leboulanger B, Aubry JM, Bondolfi G, Guy RH, Delgado-Charro MB. (2004a). Lithium monitoring by reverse iontophoresis in vivo. Clin Chem, 50, 2091–2100.
   PubMed Web of Science ®Google Scholar
• Leboulanger B, Guy RH, Delgado-Charro MB. (2004b). Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci, 22, 427–433.
   PubMed Web of Science ®Google Scholar
• Leboulanger B, Guy RH, Delgado-Charro MB. (2004c). Reverse iontophoresis for non-invasive transdermal monitoring. Physiol Meas, 25, R35–50.
   PubMed Web of Science ®Google Scholar
• Ledger PW. (1992). Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev, 9, 289–307.
   Web of Science ®Google Scholar
• Leduc S. (1900). Introduction of medicinal substances into the depth of tissues by electric current. Ann Electrobiol, 3, 545–560.
   Google Scholar
• Longo N, Li SK, Yan G, Kochambilli RP, Papangkorn K, Berglund D, Ghanem AH, Ashurst CL, Ernst SL, Pasquali M, Higuchi WI. (2007). Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria. J Inherit Metab Dis, 30, 910–915.
   PubMed Web of Science ®Google Scholar
• Li CM, Dong H, Cao X, Luong JH, Zhang X. (2007). Implantable electrochemical sensors for biomedical and clinical applications: progress, problems, and future possibilities. Curr Med Chem, 14, 937–951.
   PubMed Web of Science ®Google Scholar
• Lopez RF, Bentley MV, Delgado-Charro MB, Guy RH. (2001). Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm Res, 18, 311–315.
   PubMed Web of Science ®Google Scholar
• Lu MF, Lee D, Carlson R, Rao GS, Hui HW, Adjei L, Herrin M, Sundberg D, Hsu L. (1993). The effects of formulation variables on iontophoretic transdermal delivery of leuprolide to humans. Drug Dev Ind Pharm, 19, 1557–1571.
   Web of Science ®Google Scholar
• Luzardo-Alvarez A, Delgado-Charro MB, Blanco-Mendez J. (2001). Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharm Res, 18, 1714–1720.
   PubMed Web of Science ®Google Scholar
• Marconi B, Mancini F, Colombo P, Allegra F, Giordano F, Gazzaniga A, Orecchia G, Santi P. (1999). Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release, 60, 261–268.
   PubMed Web of Science ®Google Scholar
• Marro D, Kalia YN, Delgado-Charro MB, Guy RH. (2001). Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res, 18, 1701–1708.
   PubMed Web of Science ®Google Scholar
• Merino V, Lopez A, Hochstrasser D, Guy RH. (1999). Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release, 61, 65–69.
   PubMed Web of Science ®Google Scholar
• Mize NK, Buttery M, Daddona P, Morales C, Cormier M. (1997). Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo. Exp Dermatol, 6, 298–302.
   PubMed Web of Science ®Google Scholar
• Murdan S. (2008). Enhancing the nail permeability of topically applied drugs. Exp Opin Drug Deliv, 5, 1–16.
   PubMedGoogle Scholar
• Murthy SN, Waddell DC, Shivakumar HN, Balaji A, Bowers CP. (2007a). Iontophoretic permselective property of human nail. J Dermatol Sci, 46, 150–152.
   PubMed Web of Science ®Google Scholar
• Murthy SN, Wiskirchen DE, Bowers CP. (2007b). Iontophoretic delivery across human nail. J Pharm Sci, 96, 305–311.
   PubMed Web of Science ®Google Scholar
• Nair AB, Kim H, Chakraborty B, Singh J, Zaman M, Gupta A, Friden P, Murthy N. (2009a) DOI:10.1002/jps.21711. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci, 98.
   Web of Science ®Google Scholar
• Nair AB, Vaka SRK, Sammeta SM, Kim HD, Friden PM, Murthy N. (2009b). Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci, 98(5), 1788–1796.
   PubMed Web of Science ®Google Scholar
• Nakakura M, Kato Y, Hayakawa E, Ito K, Kuroda T. (1996). Effect of pulse on iontophoretic delivery of desmopressin acetate in rats. Biol Pharm Bull, 19, 738–740.
   PubMed Web of Science ®Google Scholar
• Nixon S, Sieg A, Delgado-Charro MB, Guy RH. (2007). Reverse iontophoresis of l-lactate: in vitro and in vivo studies. J Pharm Sci, 96, 3457–3465.
   PubMed Web of Science ®Google Scholar
• Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (zidovudine) using iontophoresis and penetration enhancer. J Control Release, 51, 161–168.
   PubMed Web of Science ®Google Scholar
• Padmanabhan RV, Phipps JB, Lattin GA, Sawchuk RJ. (1990). In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Control Release, 11, 123–135.
   Web of Science ®Google Scholar
• Panus PC, Campbell J, Kulkarni SB, Herrick RT, Ravis WR, Banga AK. (1997). Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans. J Control Release, 44, 113–121.
   Web of Science ®Google Scholar
• Patel SR, Zhong H, Sharma A, Kalia YN. (2007). In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptane succinate. Eur J Pharm Biopharm, 66, 296–301.
   PubMed Web of Science ®Google Scholar
• Patel SR, Zhong H, Sharma A, Kalia YN. (2009). Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Eur J Pharm Biopharm, 72, 304–309.
   PubMed Web of Science ®Google Scholar
• Pennington P, Caminiti S, Schein JR, Hewitt DJ, Nelson WW. (2009). Patients’ assessment of the convenience of fentanyl HCl iontophoretic transdermal system (ITS) versus morphine intravenous patient-controlled analgesia. Pain Manag Nurs, doi: 10.1016/j.pmn.2007.09.001.
   PubMed Web of Science ®Google Scholar
• Phipps JB, Padmanabhan RV, Young W, Panos R, Chester AE. (2003). E-TRANS technology. In: Drugs and the Pharmaceutical Sciences: Editors, Rathbone M, Hadgraft J, Roberts M. (Modified-Release Drug Delivery Technology) (vol. 126, pp. 499–511 ). New York: Marcel Dekker.
   Google Scholar
• Pikal MJ. (1992). The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Del Rev, 9, 201–237.
   Web of Science ®Google Scholar
• Rao G, Glikfeld P, Guy RH. (1993) Reverse iontophoresis: development of a non invasive approach for glucose monitoring. Pharm Res, 10, 1751–1755.
   PubMed Web of Science ®Google Scholar
• Rao G, Guy RH, Glikfeld P, LaCourse WR, Leung L, Tamada J, Potts RO, Azimi N. (1995). Reverse iontophoresis: non invasive glucose monitoring in vivo in humans. Pharm Res, 12, 1869–1873.
   PubMed Web of Science ®Google Scholar
• Riviere JE, Monteiro-Riviere NA, Inman AO. (1992a). Determination of lidocaine concentrations in skin after transdermal iontophoresis: effect of vasoactive drugs. Pharm Res, 9, 211–214.
   PubMed Web of Science ®Google Scholar
• Riviere JE, Williams PL, Hillman RS, Mishky LM. (1992b). Quantitative prediction of transdermal iontophoretic delivery of arbutamine in humans with the in vitro isolated perfused procine skin flap. J Pharm Sci, 81, 504–507.
   PubMed Web of Science ®Google Scholar
• Santi P, Guy., RH. (1996). Reverse iontophoresis—parameters determining electroosmotic flow: I. pH and ionic strength. J Control Release, 38, 159–165.
   Web of Science ®Google Scholar
• Scott ER, Phipps JB, Gyory JR, Padmanabhan RV. (2000). Electrotransport systems for transdermal delivery: a practical implementation of iontophoresis In: Wise DL, ed. Handbook of Pharmaceutical Controlled Release Technology (pp. 617–659. ). New York: Marcel Dekker.
   Google Scholar
• Shukla C, Friden P, Juluru R, Stagni G. (2008). In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. J Pharm Sci, 98, 917–925.
   Web of Science ®Google Scholar
• Sekkat N, Naik A, Kalia YN, Glikfeld P, Guy RH. (2002). Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J Control Release, 81, 83–89.
   PubMed Web of Science ®Google Scholar
• Sieg A, Guy RH, Delgado-Charro MB. (2004a). Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin Chem, 50, 1383–1390.
   PubMed Web of Science ®Google Scholar
• Sieg A, Guy RH, Delgado-Charro MB. (2004b). Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm Res, 21, 1807–1812.
   Google Scholar
• Sieg A, Delgado-Charro MB, Guy RH. (2005). Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabet Technol Therapeut, 7, 174–197.
   PubMedGoogle Scholar
• Sieg A, Jeanneret F, Fathi M, Hochstrasser D, Rudaz S, Veuthey JL, Guy RH, Delgado-Charro MB. (2008). Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro. Eur J Pharm Biopharm, 70, 908–913.
   PubMed Web of Science ®Google Scholar
• Singh P, Roberts MS, Maibach HI. (1995). Modelling of plasma levels of drugs following transdermal iontophoresis. J Control Release, 33, 293–298.
   Web of Science ®Google Scholar
• Slough CL, Spinelli MJ, Kasting GB. (1988). Transdermal delivery of etodronate (EHDP) in the pig via iontophoresis. J Membr Sci, 35, 161–165.
   Web of Science ®Google Scholar
• Smith KJ, Konzelman FA, Lombardo FA, Skelton HG, Holland TT, Yeager J, Wagner KF, Oster CN, Chung R. (1992). Iontophoresis of vinblastine into normal skin and for treatment of Kaposi’s sarcoma in human immunodeficiency virus-positive patients. The Military Consortium for Applied Retroviral Research. Arch Dermatol, 128, 1365–1370.
   PubMed Web of Science ®Google Scholar
• Sung KC, Fang JY, Hu OY. (2000). Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. J Control Release, 67, 1–8.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Iga K, Yanai S, Matsumoto Y, Kawase M, Fukuda T, Adachi H, Higo N, Ogawa Y. (2001). Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34). J Pharm Pharmacol, 53, 1227–1234.
   PubMed Web of Science ®Google Scholar
• Sylvestre JP, Guy RH, Delgado-Charro MB. (2008). In vitro optimization of dexamethasone phosphate delivery by iontophoresis. Phys Ther, 88, 1177–1185.
   PubMed Web of Science ®Google Scholar
• Tamada JA, Bohannon NJ, Potts RO. (1995). Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med, 1, 1198–1201.
   PubMed Web of Science ®Google Scholar
• Thysman S, Hanchard C, Preat V. (1994). Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol, 46, 725–730.
   PubMed Web of Science ®Google Scholar
• Tierney MJ, Tamada JA, Potts RO, Jovanovic L, Garg S; the Cygnus Research Team. (2001). Clinical evaluation of the GlucoWatch Biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron, 16, 621–629.
   PubMed Web of Science ®Google Scholar
• Van der Geest R, van Laar T, Gubbens-Stibbe JM, Bodde HE, Danhof M. (1997). Iontophoretic delivery of apomorphine. An in vivo study in patients with Parkinson’s disease. Pharm Res, 14, 1804–1810.
   PubMed Web of Science ®Google Scholar
• Volpato NM, Nicoli S, Laureri C, Colombo P, Santi P. (1998). In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release, 50, 291–296.
   PubMed Web of Science ®Google Scholar
• Wang Y, Thakur R, Fan Q, Michniak B. (2005). Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm, 60, 179–191.
   PubMed Web of Science ®Google Scholar
• Wascotte V, Preat V. (2006). Topical delivery by iontophoresis. In: Paye M, Barel AO, Maibach HI, eds. Handbook of Cosmetic Science and Technology (pp. 189–200 ). 2nd ed. London, UK: Taylor & Francis.
   Google Scholar
• Wascotte V, Rozet E, Salvaterra A, Hubert P, Jadoul M, Guy RH, Preat V. (2008). Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo. Eur J Pharm Biopharm, 69, 1077–1082.
   PubMed Web of Science ®Google Scholar
• Wearley L, Lui JC, Chien YW. (1989). Iontophoresis-facilitated transdermal delivery of verapamil: II. Factors affecting reversibility of skin permeability. J Control Release, 9, 231–242.
   Web of Science ®Google Scholar
• Welch ML, Grabski WJ, McCollough ML, Skelton HG, Smith KJ, Menon PA. (1997). 5-Fluorouracil iontophoretic therapy for Bowen’s disease. J Am Acad Dermatol, 36, 956–958.
   PubMed Web of Science ®Google Scholar
• Zakzewski CA, Li JK. (1991). Pulsed mode constant current iontophoretic transdermal metoprolol tartrate delivery in established acute hypertensive rabbits. J Control Release, 17, 157–162.
   Web of Science ®Google Scholar
• Zakzewski CA, Amory DW, Jasaitis DK, Li JK. (1992). Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: preliminary report. Cardiovasc Drugs Ther, 6, 589–595.
   PubMed Web of Science ®Google Scholar